ascvd risk reduction therapy: beyond statinsmultiple coronary arteries. sites with intimal thickness...

36

Upload: others

Post on 26-Dec-2019

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 2: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 3: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 4: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 5: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 6: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 7: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 8: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 9: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 10: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 11: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 12: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 13: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 14: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 15: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 16: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 17: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 18: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 19: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 20: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 21: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 22: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 23: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 24: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 25: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 26: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 27: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 28: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 29: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 30: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 31: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 32: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 33: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 34: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 35: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574
Page 36: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries. Sites with intimal thickness mm were defined as atherosclerotic. A total of sites within 1477 segments in 574